Prostate Cancer: Screening
The question
To ask the Secretary of State for Health and Social Care, whether the recent review by the UK National Screening Committee of evidence on prostate cancer screening considered the potential value for money of adopting (a) shorter and (b) simplified MRI protocols, including biparametric MRI, to reduce unit costs of prostate cancer screening in NHS settings.
Answered by Ashley Dalton
The evidence considered by the UK National Screening Committee (UK NSC) is available in the consultation on their prostate cancer recommendation page at the following link:
https://view-health-screening-recommendations.service.gov.uk/prostate-cancer/
The pathway considered the use of multiparametric magnetic resonance imaging as per National Institute for Health and Care Excellence guidance.
It is important to note that cost effectiveness is only one of the criteria that the UK NSC uses to assess the case for screening. Benefits, harms, acceptability, feasibility, and test characteristics are all important.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →